Editorial: Assessment and management of adverse drug reactions in oncology.
作者信息
Tsai Ping-Feng, Ma Kevin Sheng-Kai
机构信息
Department of Ophthalmology, Tri-Service General Hospital, Taipei, Taiwan.
Division of Pharamacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, United States.
出版信息
Front Allergy. 2023 Jul 13;4:1223078. doi: 10.3389/falgy.2023.1223078. eCollection 2023.
Abstract
摘要
相似文献
1
Editorial: Assessment and management of adverse drug reactions in oncology.社论：肿瘤学中药物不良反应的评估与管理
Front Allergy. 2023 Jul 13;4:1223078. doi: 10.3389/falgy.2023.1223078. eCollection 2023.
2
Assessing carbamazepine and oxcarbazepine-associated Stevens-Johnson syndrome/toxic epidermal necrolysis: Data mining the public version of the FDA adverse event reporting system.评估卡马西平和奥卡西平相关的史蒂文斯-约翰逊综合征/中毒性表皮坏死松解症：从 FDA 不良事件报告系统公开版本中挖掘数据。
Int J Clin Pract. 2021 Aug;75(8):e14273. doi: 10.1111/ijcp.14273. Epub 2021 May 17.
3
Retrospective study of 213 cases of Stevens-Johnson syndrome and toxic epidermal necrolysis from China.对来自中国的213例史蒂文斯-约翰逊综合征和中毒性表皮坏死松解症病例的回顾性研究。
Burns. 2020 Jun;46(4):959-969. doi: 10.1016/j.burns.2019.10.008. Epub 2019 Dec 30.
4
5
Immune checkpoint inhibitor-related dermatologic adverse events.免疫检查点抑制剂相关的皮肤不良反应。
J Am Acad Dermatol. 2020 Nov;83(5):1255-1268. doi: 10.1016/j.jaad.2020.03.132. Epub 2020 May 23.
6
Adverse cutaneous toxicities by PD-1/PD-L1 immune checkpoint inhibitors: pathogenesis, treatment, and surveillance.PD-1/PD-L1 免疫检查点抑制剂的皮肤毒性不良反应：发病机制、治疗和监测。
Cutan Ocul Toxicol. 2022 Mar;41(1):73-90. doi: 10.1080/15569527.2022.2034842. Epub 2022 Feb 20.
7
Cutaneous Immune-Related Adverse Events (irAEs) to Immune Checkpoint Inhibitors: A Dermatology Perspective on Management.免疫检查点抑制剂相关的皮肤免疫不良反应（irAEs）：皮肤科管理视角
J Cutan Med Surg. 2021 Jan-Feb;25(1):59-76. doi: 10.1177/1203475420943260. Epub 2020 Aug 3.
8
Management of immune checkpoint inhibitor-related dermatologic adverse events.免疫检查点抑制剂相关皮肤不良反应的管理。
Thorac Cancer. 2020 Feb;11(2):488-492. doi: 10.1111/1759-7714.13275. Epub 2019 Dec 9.
9
Evaluation of Combination Therapy With Etanercept and Systemic Corticosteroids for Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: A Multicenter Observational Study.评价依那西普联合全身皮质类固醇治疗史蒂文斯-约翰逊综合征和中毒性表皮坏死松解症的疗效：一项多中心观察性研究。
J Allergy Clin Immunol Pract. 2022 May;10(5):1295-1304.e6. doi: 10.1016/j.jaip.2022.01.038. Epub 2022 Feb 4.
10
Immune checkpoint inhibitor-related Stevens-Johnson syndrome/toxic epidermal necrolysis-like reactions.免疫检查点抑制剂相关的史蒂文斯-约翰逊综合征/中毒性表皮坏死松解症样反应。
J Am Acad Dermatol. 2021 Aug;85(2):e109. doi: 10.1016/j.jaad.2021.03.122. Epub 2021 Apr 18.
本文引用的文献
1
The incidence and risk of cardiovascular events associated with immune checkpoint inhibitors in Asian populations.亚洲人群中与免疫检查点抑制剂相关的心血管事件的发生率和风险。
Jpn J Clin Oncol. 2022 Dec 5;52(12):1389-1398. doi: 10.1093/jjco/hyac150.
2
Association of Bullous Pemphigoid With Immune Checkpoint Inhibitor Therapy in Patients With Cancer: A Systematic Review.癌症患者接受免疫检查点抑制剂治疗与大疱性类天疱疮的关联：一项系统评价。
JAMA Dermatol. 2022 Aug 1;158(8):933-941. doi: 10.1001/jamadermatol.2022.1624.
3
Acute Interstitial Nephritis and Checkpoint Inhibitor Therapy: Single Center Experience of Management and Drug Rechallenge.急性间质性肾炎与检查点抑制剂治疗：管理和药物再挑战的单中心经验。
Kidney360. 2020 Jan 7;1(1):16-24. doi: 10.34067/KID.0000152019. eCollection 2020 Jan 30.
4
Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: ASCO Guideline Update.免疫检查点抑制剂治疗患者免疫相关不良反应的管理：ASCO 指南更新。
J Clin Oncol. 2021 Dec 20;39(36):4073-4126. doi: 10.1200/JCO.21.01440. Epub 2021 Nov 1.
5
Ocular manifestations of anti-neoplastic immune checkpoint inhibitor-associated Stevens-Johnson syndrome/toxic epidermal necrolysis in cancer patients.癌症患者中抗肿瘤免疫检查点抑制剂相关的史蒂文斯-约翰逊综合征/中毒性表皮坏死松解症的眼部表现
Ocul Surf. 2021 Oct;22:47-50. doi: 10.1016/j.jtos.2021.06.010. Epub 2021 Jun 30.
6
Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immune checkpoint inhibitor-related adverse events.癌症免疫治疗学会（SITC）免疫检查点抑制剂相关不良反应临床实践指南。
J Immunother Cancer. 2021 Jun;9(6). doi: 10.1136/jitc-2021-002435.
7
Human leucocyte antigen association of patients with Stevens-Johnson syndrome/toxic epidermal necrolysis with severe ocular complications in Han Chinese.汉族史蒂文斯-约翰逊综合征/中毒性表皮坏死松解症伴严重眼部并发症患者的人类白细胞抗原关联
Br J Ophthalmol. 2022 May;106(5):610-615. doi: 10.1136/bjophthalmol-2020-317105. Epub 2021 Jan 13.
8
Cardiovascular Toxicity of Immune Checkpoint Inhibitors: Clinical Risk Factors.免疫检查点抑制剂的心血管毒性：临床危险因素。
Curr Oncol Rep. 2021 Jan 7;23(2):13. doi: 10.1007/s11912-020-01002-w.
9
Correspondence to 'Hypersensitivity reactions with allopurinol and febuxostat: a study using the Medicare claims data'.致《别嘌醇与非布司他引起的超敏反应：一项使用医疗保险理赔数据的研究》
Ann Rheum Dis. 2022 Jun;81(6):e107. doi: 10.1136/annrheumdis-2020-218090. Epub 2020 Jun 19.
10
Bullous pemphigoid after anti-programmed death-1 therapy: A retrospective case-control study evaluating impact on tumor response and survival outcomes.抗程序性死亡-1治疗后发生大疱性类天疱疮：一项评估对肿瘤反应和生存结果影响的回顾性病例对照研究。
J Am Acad Dermatol. 2022 Dec;87(6):1400-1402. doi: 10.1016/j.jaad.2019.12.068. Epub 2020 Jan 10.
Zotero 插件